FolioDesk

Keros Therapeutics, Inc. (KROS)

Nasdaq: KROS · CIK 0001664710 · United States

Every official Keros Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Open KROS filings

Keros Therapeutics, Inc. documents

More companies